| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/05/2011 | CN102205131A Preparation method and application of DNA (deoxyribonucleic acid) vaccine of influenza A (H1N1) |
| 10/05/2011 | CN102205124A Composition for inhibition of expression of miR-27b, medicines containing the same, and use for the same |
| 10/05/2011 | CN102205112A BMP composition for synergistic induction of ossification differentiation, and application thereof |
| 10/05/2011 | CN102204930A Improved modalities for the treatment of degenerative diseases of the retina |
| 10/05/2011 | CN101816798B Gene vaccine of sperm-specific protein Ropporin and preparation method thereof |
| 10/05/2011 | CN101705227B SiRNA for inhibiting human AP-2alpha gene expression and anti-cervical cancer application thereof |
| 10/05/2011 | CN101319229B Recombined human bFGF and PDGF-B duplicate adenovirus carrier and uses thereof |
| 10/05/2011 | CN101270361B Japanese blood fluke TSP protein extracellular cyclo-2 encoding gene, polypeptide, amalgamation protein and uses in preparing vaccine |
| 10/05/2011 | CN101199859B Inhibition lung cancer transfer and lung transfer tumor gene medicament |
| 10/05/2011 | CN101177684B Sheep brucella M5 strain ribosome protein L7/L12 gene, encoding protein and uses thereof |
| 10/05/2011 | CN101132694B Medical device with coating for capturing genetically-altered cells and methods of using same |
| 10/04/2011 | US8030537 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 10/04/2011 | US8030476 siRNA targeting gremlin |
| 10/04/2011 | US8030474 siRNA targeting cyclin-dependent kinase 4 (CDK4) |
| 10/04/2011 | US8030456 Nogo receptor antagonists |
| 10/04/2011 | US8030287 DNA vaccine against North American spring viremia of carp virus |
| 10/04/2011 | US8030286 decreasing elongation factor 2 (eEF2) kinase activity in cell by reducing expression of a gene encoding the eEF2 kinase; hypoxia, anoxia, ischemia, stroke, and neurogenerative diseases; polynucleotide biodrugs; regulating protein turnover, protect cell due to stress, exposure to chemotherapy, radiation |
| 10/04/2011 | US8030284 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs |
| 10/04/2011 | US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides |
| 10/04/2011 | US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 10/04/2011 | US8030029 Flu vaccines and methods of use thereof |
| 10/04/2011 | US8029779 Claims are for a nitrogen oxide sensor electrode and do not match rest of document; Lactobacillus delbrueckii with antifungal activity and use as a probiotic |
| 10/04/2011 | US8029778 Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3 |
| 10/04/2011 | US8029777 Helicobacter system and uses thereof |
| 10/04/2011 | US8029776 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 10/04/2011 | CA2480308C Antisense iap nucleobase oligomers and uses thereof |
| 10/04/2011 | CA2470539C Islet cells from human embryonic stem cells |
| 10/04/2011 | CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 10/04/2011 | CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 10/04/2011 | CA2224075C Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 09/29/2011 | WO2011120045A1 Ectodomains of influenza matrix 2 protein, expression system, and uses thereof |
| 09/29/2011 | WO2011119890A1 Neurod1 gene expression in non-endocrine pancreatic epithelial cells (nepecs) |
| 09/29/2011 | WO2011118994A2 Nlk as a marker for diagnosis of liver cancer and as a therapeutic agent thereof |
| 09/29/2011 | WO2011118981A2 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer |
| 09/29/2011 | WO2011118819A1 Gene therapy for hematopoietic tumor by proliferation-regulated virus vector carrying survivin promoter |
| 09/29/2011 | WO2011118779A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 09/29/2011 | WO2011118778A1 Cell proliferation suppression agent and method for screening same |
| 09/29/2011 | WO2011117582A1 Dendritic cell inhibitory proteins from ticks |
| 09/29/2011 | WO2011117401A1 Use of pcsk9 as a vaccine for lowering cholesterol |
| 09/29/2011 | WO2011117258A2 Methods of increasing efficiency of vector penetration of target tissue |
| 09/29/2011 | WO2011070214A8 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 09/29/2011 | WO2011034947A3 Reagents and methods for modulating cone photoreceptor activity |
| 09/29/2011 | US20110239319 Use of Endonucleases for Inserting Transgenes Into Safe Harbor Loci |
| 09/29/2011 | US20110237653 Rna vector therapy method |
| 09/29/2011 | US20110237652 Detection and destruction of cancer cells using programmed genetic vectors |
| 09/29/2011 | US20110236562 Film preparation and process for preparing the same |
| 09/29/2011 | US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/29/2011 | US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/29/2011 | US20110236325 Methods to treat or prevent a skin condition using a nell1 peptide |
| 09/29/2011 | CA2793772A1 Ectodomains of influenza matrix 2 protein, expression system, and uses thereof |
| 09/28/2011 | EP2369002A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 09/28/2011 | EP2368989A1 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus |
| 09/28/2011 | EP2368985A2 Compositions and methods for generating an immune response |
| 09/28/2011 | EP2368903A1 Adenovirus derived helper virus for enhancing recombinant parvovirus production |
| 09/28/2011 | EP2368902A2 Insulin and IGF-1 receptor agonists and antagonists |
| 09/28/2011 | EP2368575A2 Dry formulation for transcutaneous immunization |
| 09/28/2011 | EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides |
| 09/28/2011 | EP2367939A1 Methods for diagnosing or treating prostate cancer |
| 09/28/2011 | EP2367555A2 Regenerating and enhancing development of muscle tissue |
| 09/28/2011 | EP2367527A2 Implantable ocular drug delivery device and methods |
| 09/28/2011 | EP1463531B1 Methods for inhibiting ocular processes |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1355669B1 Augmented cognitive training |
| 09/28/2011 | EP1322307B1 Methods for treating cell proliferative disorders and viral infections |
| 09/28/2011 | EP1263965B1 Avirulent, immunogenic flavivirus chimeras |
| 09/28/2011 | EP0777732B1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/28/2011 | CN1750843B Methods and compositions for inducing apoptosis in cancer cells |
| 09/28/2011 | CN102203291A Tbc1d7 as tumor marker and therapeutic target for cancer |
| 09/28/2011 | CN102203255A RNA antagonists targeting HSP27 |
| 09/28/2011 | CN102203254A Sirna compositions and methods for potently inhibiting viral infection |
| 09/28/2011 | CN102203250A Syngr4 for target genes of cancer therapy and diagnosis |
| 09/28/2011 | CN102202693A Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells |
| 09/28/2011 | CN102199626A Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| 09/28/2011 | CN102199618A Method for constructing mutant recombinant plasmid of PPARalpha gene V227A |
| 09/28/2011 | CN102199612A Nucleotide sequence used in preparation of Mycobacterium smegmatis vaccine and application thereof |
| 09/28/2011 | CN102199611A Clostridium difficile exotoxin A carboxy-terminal gene sequence with optimized codon and nucleic acid vaccine thereof |
| 09/28/2011 | CN102199608A Efficient expression of pinellia ternate agglutinin (PTA) in bombyx mori reactor |
| 09/28/2011 | CN102199603A Multi-target interfering RNA (Ribonucleic Acid) molecule and application thereof |
| 09/28/2011 | CN102199216A New dendritic cell co-stimulatory molecules |
| 09/28/2011 | CN102199199A Membrane localization staphylococcal enterotoxin A and gene sequence thereof |
| 09/28/2011 | CN102199197A Polypeptides with function of self-assembled potassium channel and its application |
| 09/28/2011 | CN102198277A Dual-targeting gene treatment vector for liver cancer and preparation method thereof |
| 09/28/2011 | CN102198276A Application of chylomicron as liver targeting gene treatment vector |
| 09/28/2011 | CN102198275A Recombinant plasmid DNA vaccine for treating hepatitis b |
| 09/28/2011 | CN102198268A Recombinant Swine pox virus (SPV) vector vaccine for the expression of Streptococcus equi subsp zooepidemicus (SEZ) M-like protein (SzP) |
| 09/28/2011 | CN102198264A Beta-defensin 15 of specific antibacterial peptides of rat epididymis and application thereof |
| 09/28/2011 | CN101748124B siRNA segment and application thereof used for curing and/or preventing Peste des petits ruminants |
| 09/28/2011 | CN101703783B Method for preparing glucocorticoid grafted gene drug delivery vector |
| 09/28/2011 | CN101659958B Multi-titer live vaccine as well as preparation method and application thereof |
| 09/28/2011 | CN101524529B Treatment on human malignant solid tumor by HNF4 alpha inducement and differentiation |
| 09/28/2011 | CN101130091B DNA vaccine for treating atrophic arthritis and uses of the same |
| 09/27/2011 | US8026346 Tribonectins |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026225 Short nucleic acid molecule-mediated modulation of Aurora B kinase expression and combinations for use in anticancer therapy |
| 09/27/2011 | US8026224 Tumor cells with increased immunogenicity and uses therfor |
| 09/27/2011 | US8026223 Treating malignant tumors with high field strength electroporation of plasmids encoding IL-12 |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | US8025887 Avirulent, immunogenic flavivirus chimeras |
| 09/27/2011 | CA2506476C Method of treatment of myocardial infarction |
| 09/27/2011 | CA2408034C Recombinant sequence, its preparation and use |